Related Experiment Video
Updated: Apr 18, 2026

10:00
An Ultrahigh-throughput Microfluidic Platform for Single-cell Genome Sequencing
Published on: May 23, 2018
18.5K
Scalable genotyping in fixed transcriptomes resolves clonal heterogeneity via single-cell sequencing
Sydney B Blattman1, Nabih Maslah1,2, Austin A Varela1
1Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.
Biorxiv : the Preprint Server for Biology
|April 17, 2026
Summary
Genotyping in Fixed Transcriptomes (GIFT) links genetic mutations to cell states in thousands of cells. This new method reveals how mutations like JAK2V617 drive disease in myeloproliferative neoplasms.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Single-cell transcriptomics offers insights into cell heterogeneity.
- Linking transcriptional states to somatic mutations in single cells remains a challenge.
- Existing platforms have limitations in simultaneous genetic and transcriptomic profiling.
Purpose of the Study:
- Introduce Genotyping in Fixed Transcriptomes (GIFT), a novel assay.
- Enable simultaneous detection of genetic variants and transcriptome profiles in single cells.
- Facilitate clonal lineage tracing and genotype-to-phenotype relationship resolution.
Main Methods:
- Developed a novel assay (GIFT) using gapfilling reactions between ssDNA probes.
- Barcodes native transcript sequences for highly specific mutation detection.
- Achieved high genotyping accuracy (>99%) and flexible capture of hundreds of mutations per cell.
- Applied GIFT to profile over 700,000 cells from myeloproliferative neoplasm (MPN) patients.
Main Results:
- Demonstrated GIFT's scalability and accuracy, including in FFPE tissues.
- Revealed mutation-dependent hematopoietic responses to inflammation in MPNs.
- Identified an allelic dose gradient of interferon-associated programs linked to JAK2V617.
- Showcased GIFT's ability to trace clonal lineages and link genotype to phenotype.
Conclusions:
- GIFT overcomes technical limitations in single-cell mutation and transcriptome analysis.
- Enables comprehensive cell state measurements and clonal lineage tracing at single-cell resolution.
- Provides new insights into genotype-to-phenotype relationships in complex diseases like MPNs.
More Related Videos
Related Concept Videos
Next-generation Sequencing
102.2K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
102.2K
RNA-seq
12.7K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.7K

